Insulet Corporation
NASDAQPODD enters the back half of August in an uncomfortable spot — down 12% over the past month, with analysts still scrambling to reset expectations after a sharp post-earnings sell-off earlier in the month, and the CEO quietly buying stock near multi-year lows. The most striking development in recent weeks is how aggressively short sellers have pulled back. Short interest has fallen…
PODD put/call ratio spikes to 0.7668, 4.0 standard deviations above its 20-day mean of 0.3787—the most extreme defensive options positioning in 52 weeks, signaling a sharp reversal to heavy put buying after the August 5 earnings crash.
PODD enters the back half of August in an uncomfortable spot — down 12% over the past month, with analysts still scrambling to reset expectations after a sharp post-earnings sell-off earlier in the month, and the CEO…
Insulet Corporation reports Q2 results today having already delivered the move — shares fell 20% on August 5 to $133.26, erasing a month of tentative recovery in a single session and leaving the stock down roughly 19%…
Snapshot as of 20 Sept 2026
Insulet Corporation reported Q2 results after the close on August 6, and the pre-print setup told a coherent story: bulls held the floor in options, shorts were retreating, and the Street kept its ratings despite…
Insulet Corporation reports Q2 results on August 6 with a street that has spent the past month trimming targets yet holding its ratings — a setup where conviction remains intact but patience is being tested. The most…
Insulet Corporation enters the week of July 7 with a striking divergence: options traders have rarely been this bullish on the stock, even as short sellers quietly rebuild positions and the Street cuts targets ahead of…
Insulet Corporation has dropped another 7.4% this week to $142.43 — extending a brutal month that has now cost shareholders nearly 19% — yet the short-side narrative remains stubbornly muted. The most interesting…
Insulet Corporation enters the post-earnings stretch with the Street's price targets dramatically lower — yet the direction of conviction remains firmly bullish. The analyst response to May's results has been one of…
Insulet Corporation reports Q1 results on May 20 with the stock down 27% in a month and the Street scrambling to reset expectations — the real question tomorrow is whether the guidance floor has finally been set. The…
PODD enters its Q1 2026 earnings report — due today — with the most bullish options positioning of the past year and a stock that has lost more than a quarter of its value in a month. The options market has made a…
Insulet Corporation enters its Q1 2026 earnings release — due after the close on May 7 — with a sharp divergence between a battered stock price and the most call-heavy options positioning it has seen all year. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PODD — free to start on ORTEX.
Sign up for free →Open PODD on ORTEX